These lesions fall into the molecular classification of HER2 positive cases and basal cancers as opposed to the remainder which are of luminal type A and B. Recurrences of DCIS have been noted by others in each of these categories [17, 20]. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.